in vivo studies of mesoprefrontal da synthesis are therefore complicated by the necessity to distinguish between effects of dopaminergic drugs on synthesis-modulating autoreceptors and effects resulting from increased end product inhibition of tyrosine hydroxylase ( th ) secondary to decreased da release .
C0282151
dopaminergic
C0013030
da